Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial sorbitol-specific phosphotransferase system (PTS) transporter is a specialized membrane-bound protein complex that facilitates the uptake and simultaneous phosphorylation of D-sorbitol into the bacterial cell. This system is part of the broader phosphoenolpyruvate (PEP)-dependent PTS, which is unique to bacteria and absent in eukaryotic cells, making it a promising target for selective antimicrobial therapy (Postma et al., 1993, Microbiol Rev). The transporter typically consists of three functional units: the cytoplasmic EIIA and EIIB domains and the membrane-integrated EIIC permease, which together coordinate the transfer of a phosphate group from PEP to the substrate during translocation (UniProt, 2024). In pathogens such as Listeria monocytogenes and Escherichia coli, the ability to utilize sorbitol via this transporter is often linked to environmental fitness and virulence within the host (Heo et al., 2007, J Bacteriol). While no clinical drugs currently target this specific transporter, experimental sorbitol analogs and PTS inhibitors are being explored to disrupt bacterial metabolism and biofilm formation (Kaur et al., 2020, Front Microbiol). Targeting this system offers a strategy to starve specific pathogens or modulate the composition of the microbiome without affecting human metabolic pathways. Furthermore, the specificity of the EII component for sorbitol allows for the potential development of narrow-spectrum agents that spare non-target species. Research into this transporter also extends to its role in dental caries, where sorbitol-utilizing bacteria like Streptococcus mutans contribute to acid production in the oral cavity.
Competitive inhibition of sorbitol binding or disruption of the phosphorylation-coupled transport mechanism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial sorbitol-specific phosphotransferase system transporter (Sorbitol-PTS).